Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
Na Li, Ruijia Zhang, Minghai Tang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14447-14473
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Inflammasome components as new therapeutic targets in inflammatory disease
Rebecca C. Coll, Kate Schroder
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 29
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
Juraj Velcicky, Philipp Janser, Nina Gommermann, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1544-1562
Closed Access | Times Cited: 24
Degrading the key component of the inflammasome: Development of an NLRP3 PROTAC
Tim Keuler, Dominic Ferber, Jonas Engelhardt, et al.
Chemical Communications (2025)
Closed Access | Times Cited: 1
Mechanisms and Therapeutic Strategies for NLRP3 Degradation via Post-Translational Modifications in Ubiquitin-proteasome and Autophagy Lysosomal Pathway
Kaiyue Su, Minghai Tang, Jie Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117476-117476
Closed Access | Times Cited: 1
The NLRP3 Inflammasome as a Pathogenic Player Showing Therapeutic Potential in Rheumatoid Arthritis and Its Comorbidities: A Narrative Review
Po‐Ku Chen, Kuo‐Tung Tang, Der‐Yuan Chen
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 626-626
Open Access | Times Cited: 8
Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury
Simone Gastaldi, Magalì Giordano, Federica Blua, et al.
Vascular Pharmacology (2024) Vol. 156, pp. 107397-107397
Open Access | Times Cited: 6
Association between silicosis and autoimmune disease
Elizabeth Fireman, Einat Fireman Klein
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 2, pp. 45-50
Open Access | Times Cited: 5
Discovery of Potent, Specific, and Orally Available NLRP3 Inflammasome Inhibitors Based on Pyridazine Scaffolds for the Treatment of Septic Shock and Peritonitis
Zhiyuan Fu, Yangqin Duan, Heying Pei, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 15711-15737
Closed Access | Times Cited: 5
Metabolite-sensing GPCRs in rheumatoid arthritis
Xuezhi Yang, Wankang Zhang, Luping Wang, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 2, pp. 118-133
Closed Access | Times Cited: 4
Hypocrellin A from an ethnic medicinal fungus protects against NLRP3-driven gout in mice by suppressing inflammasome activation
Yan Li, Shuang Qi, Chao Wu, et al.
Acta Pharmacologica Sinica (2024)
Closed Access | Times Cited: 4
TLR/NLRP3 Inflammasome signaling pathways as a main target in frailty, cachexia and sarcopenia
Sanaz Keshavarz Shahbaz, Aida Mokhlesi, Roghaye Keshavarz Sadegh, et al.
Tissue and Cell (2025) Vol. 93, pp. 102723-102723
Closed Access
Peripheral Evolution of Tanshinone IIA and Cryptotanshinone for Discovery of a Potent and Specific NLRP3 Inflammasome Inhibitor
Wenqi Zhu, Xiaodong Bao, Yuyan Yang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of Potent and Brain-Penetrant Bicyclic NLRP3 Inhibitors with Peripheral and Central In Vivo Activity
Oscar Mammoliti, Rodrigo J. Carbajo, Laura Pérez‐Benito, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
In vitro and in vivo characterization of oridonin analogs as anti-inflammatory agents that regulate the NF-κB and NLRP3 inflammasome axis
Huiping Ou, Zhanpan Wu, Jinhua Ning, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Discovery, Synthesis, and Biological Mechanism Evaluation of Novel Quinoline derivatives as Potent NLRP3 Inhibitors
Ruiwen Wu, Yuyun Yan, Zhuorong Liu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117466-117466
Closed Access
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
Dong-Ming Shen, Kate F. Byth, Damien Bertheloot, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of novel NLRP3 inhibitors enabled by a high-throughput screen
Stéphane Dorich, Anick Auger, Li Wang, et al.
Bioorganic & Medicinal Chemistry Letters (2025), pp. 130184-130184
Closed Access
Discovery of Novel Sulfonylurea NLRP3 Inflammasome Inhibitor for the Treatment of Multiple Inflammatory Diseases
Yiting Liu, Qinxue Wang, Jinyu Ma, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Structure Optimization of Natural Product Piperine to Obtain Novel and Potent Analogs with Anti-inflammation Pain and Urate-Lowering Effect
Chunxia Liu, Wenxin Wang, Ruoyang Miao, et al.
European Journal of Medicinal Chemistry (2025), pp. 117649-117649
Closed Access
Exploring the Structure–Activity Relationship of F. velutipes Polysaccharide: A Novel Promising Anti-Inflammatory and Intestinal Barrier-Protective Molecule Extracted by Ultrasound
Xin Chen, Jingsi Zhang, Qiping Zhan, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Understanding a Potential Role for the NLRP3 Inflammasome in Placenta‐Mediated Pregnancy Complications
Chloe Moss, Mark Dilworth, Lynda K. Harris, et al.
American Journal of Reproductive Immunology (2025) Vol. 93, Iss. 4
Open Access
The molecular mechanisms, roles, and potential applications of PANoptosis in cancer treatment
Wenyuan Ma, Qiang Wang, Lanfang Guo, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Advancements in Predictive Medicine: NLRP3 Inflammasome Inhibitors and AI-Driven Predictive Health Analytics
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 3, pp. 331-333
Open Access | Times Cited: 3
Oridonin attenuates liver ischemia–reperfusion injury by suppressing PKM2/NLRP3-mediated macrophage pyroptosis
Xin-yi Wu, Minjie Zhao, Wei Liao, et al.
Cellular Immunology (2024) Vol. 401-402, pp. 104838-104838
Closed Access | Times Cited: 3
Local Scaffold Diversity-Contributed Generator for Discovering Potential NLRP3 Inhibitors
Weichen Bo, Yangqin Duan, Yurong Zou, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 3, pp. 737-748
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top